Multisite Trial Early Data Suggests Remdesivir is Effective (UW Medicine Newsroom, Interview with Helen Chu)

Remdesivir, a non-specific antiviral drug that was originally tested against Ebola, has been shown to be effective against the new coronavirus in a preliminary data analysis, as reported by the National Institutes of Health. The UW School of Medicine was one of the sites in the National Institutes of Health trial. Dr.

Studies Show that COVID-19 Can Spread Quickly in Homeless Communities

Researchers have been studying COVID-19 in homeless communities, specifically in shelters with two or more confirmed cases in the weeks prior to their study. They found that in these shelters with clusters of cases, the proportion of positive tests was higher than in shelters with lower amounts of previously reported cases.

Coronavirus: Our Experts in the News

The following links are a collection of news stories about the coronavirus that either quote, include, or were written by Department of Global Health faculty and staff. This includes video interviews with local and national media outlets, as well as written stories detailing DGH's research and innovation in fighting COVID-19. 

Also see UW School of Public Health's web pages on Coronavirus Response, Resources and News

Global Health Career Week in Collaboration with the School of Public Health: Schedule, Online Registration Info, and More

Each year the Department of Global Health invites organizations to campus for our annual career fair to talk with our students about working in global and local health during Global Health Career Week. This year we are doing something a bit different and have invited a number of our regular fair participants to each host an hour long ZOOM session where they might present information on their organization, their work, the culture of hiring, job or internship opportunities that might arise, and how students might best prepare for these session.

UW Researchers Study Effects of COVID-19 on Vulnerable Populations in Africa (Study led by Judd Walson)

As the global COVID-19 pandemic spreads, there are increasing numbers of cases in low- and middle-income country (LMIC) settings, including in many African countries. A new $1.38 million UW research project funded by the Bill and Melinda Gates Foundation will monitor the spread of COVID-19 in sites in Africa in order to increase understanding of the effects of COVID-19 on vulnerable children and adults, healthcare workers and researchers in low-resource settings. 

UW to Lead National Study of Drug Promoted by President Trump to Fight Coronavirus (Seattle Times, Includes Ruanne Barnabas)

Researchers at the University of Washington on Friday announced a major new study of the malaria drug President Donald Trump has praised as a possible, low-cost cure for COVID-19.

The clinical trial is one of dozens around the world aimed at providing definitive evidence about the effectiveness of hydroxychloroquine, either alone or in combination with the antibiotic azithromycin, against the novel coronavirus.

Pages